Crossref
Position and controversy with beta-blockers in cirrhosis in 2018
Journal of Clinical Gastroenterology and Hepatology · 2018
DOI: 10.21767/2575-7733-c3-008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Gastroenterology and Hepatology, 2018. Verfasst von Triki Ismail. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ismail, T. (2018). Position and controversy with beta-blockers in cirrhosis in 2018. Journal of Clinical Gastroenterology and Hepatology. https://doi.org/10.21767/2575-7733-c3-008
Vancouver
Ismail T. Position and controversy with beta-blockers in cirrhosis in 2018. Journal of Clinical Gastroenterology and Hepatology. 2018. doi:10.21767/2575-7733-c3-008
BibTeX
@article{Ismail2018,
author = {Ismail, Triki},
title = {Position and controversy with beta-blockers in cirrhosis in 2018},
journal = {Journal of Clinical Gastroenterology and Hepatology},
year = {2018},
doi = {10.21767/2575-7733-c3-008}
}
EUVIMED